[1] Tang BS, Jiang H. Study on diagnosis and treatment of hereditary ataxia[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2012, 12:266-274.[唐北沙, 江泓. 遗传性共济失调诊断与治疗专家策略[J]. 中国现代神经疾病杂志, 2012, 12:266-274.]
[2] Liu J, Wang LN. Classification, differential diagnoses and therapy in patients with chorea[J]. Zhonghua Nei Ke Za Zhi, 2019, 58:689-692.[刘佳, 王鲁宁. 舞蹈症的临床分类和诊疗思路[J]. 中华内科杂志, 2019, 58:689-692.]
[3] Rochester L, Galna B, Lord S, Mhiripiri D, Eglon G, Chinnery PF. Gait impairment precedes clinical symptoms in spinocerebellar ataxia type 6[J]. Mov Disord, 2014, 29:252-255.
[4] Bunn LM, Marsden JF, Giunti P, Day BL. Stance instability in spinocerebellar ataxia type 6[J]. Mov Disord, 2013, 28:510-516.
[5] Isono C, Hirano M, Sakamoto H, Ueno S, Kusunoki S, Nakamura Y. Progression of dysphagia in spinocerebellar ataxia type 6[J]. Dysphagia, 2017, 32:420-426.
[6] Xu B, Tang BS, Zhang YH, Jiang H, Guo JF, Liu XM, Tang JG, Shen L. Analysis of the clinical features and genetic mutation of spinocerebellar ataxia type 6 from Chinese kindreds[J]. Lin Chuang Shen Jing Bing Xue Za Zhi, 2006, 19:81-83.[许波, 唐北沙, 张玉虎, 江泓, 郭纪锋, 刘小民, 汤建光, 沈璐. 脊髓小脑型共济失调6型患者的临床特征及基因突变分析[J]. 临床神经病学杂志, 2006, 19:81-83.]
[7] Jiang H, Tang BS, Xu HW, Shen L, Liang CH, Li XH, Duan HX. Comparative study of SPECT and MRI in examining 20 patients with olivopontocerebellar atrophy[J]. Zhonghua He Yi Xue Za Zhi, 2001, 21:87-88.[江泓, 唐北沙, 许宏伟, 沈璐, 梁昌华, 李新辉, 段华新. 橄榄桥脑小脑萎缩SPECT脑显像和MRI对比研究[J]. 中华核医学杂志, 2001, 21:87-88.]
[8] Liu J, Wang LN. Mitochondrial enhancement for neurodegenerative movement disorders:a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone[J]. CNS Drugs, 2014, 28:63-68.
[9] Liu J, Wang LN. The efficacy and safety of riluzole for neurodegenerative movement disorders:a systematic review with meta-analysis[J]. Drug Deliv, 2018, 25:43-48.